Last week, FDA launched Drug Trials Snapshot, a pilot program intended to provide consumers with information about the sex, age, race and ethnicity of clinical participants for six drugs approved in May and June 2014. This pilot is intended to solicit feedback on the content, format and usefulness of the information provided in advance of an expansion of the program to include all new molecular entities subject to an approved NDA beginning in 2015.
The Drug Trials Snapshot website was developed by FDA in response to the requirements in Section 907 of FDASIA that FDA: 1) report to ...
Blog Editors
Recent Updates
- The First National Health Care Fraud Takedown of the Second Trump Administration: What Stayed the Same and What Is New?
- Latest Moves by Federal Agencies Regarding Gender-Affirming Care: Risks Mount for Providers
- Lone Star AI: How Texas Is Pioneering President Trump’s Tech Agenda
- New OIG Advisory Opinion Approves Manufacturer’s Warranty for Injuries Caused by Medical Device
- DOJ, HHS Announce Revamped False Claims Act Working Group